HCV-associated cryoglobulinemic vasculitis: triple/dual antiviral treatment and/or rituximab? Reply to the comment by Ignatova et al
- PMID: 24969272
- DOI: 10.1136/annrheumdis-2014-206022
HCV-associated cryoglobulinemic vasculitis: triple/dual antiviral treatment and/or rituximab? Reply to the comment by Ignatova et al
Keywords: Rehabilitation; Rheumatoid Arthritis; Treatment.
Comment on
-
Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24.Ann Rheum Dis. 2014 May;73(5):831-7. doi: 10.1136/annrheumdis-2012-202770. Epub 2013 Apr 20. Ann Rheum Dis. 2014. PMID: 23606708 Free PMC article. Clinical Trial.
-
HCV-associated cryoglobulinaemic vasculitis: triple/dual antiviral treatment and/or rituximab?Ann Rheum Dis. 2014 Sep;73(9):e58. doi: 10.1136/annrheumdis-2014-205997. Epub 2014 Jun 12. Ann Rheum Dis. 2014. PMID: 24925837 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources